{"id":14397,"date":"2012-10-05T09:24:36","date_gmt":"2012-10-05T07:24:36","guid":{"rendered":"http:\/\/miunidad.eu\/porib.com\/?p=14397"},"modified":"2021-09-22T09:26:43","modified_gmt":"2021-09-22T07:26:43","slug":"farfan-sedano-fj-oyaguez-i-apezteguia-fernandez-c-casado-ma","status":"publish","type":"post","link":"https:\/\/porib.com\/en\/farfan-sedano-fj-oyaguez-i-apezteguia-fernandez-c-casado-ma\/","title":{"rendered":"Farfan Sedano FJ, Oyag\u00fcez I, Apeztegu\u00eda Fern\u00e1ndez C, Casado MA"},"content":{"rendered":"<div class=\"col80\">\n<p class=\"miniatura_foto\" style=\"text-align: justify;\"><strong><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-14058 alignleft\" src=\"https:\/\/porib.com\/wp-content\/uploads\/2021\/09\/SEFH-.jpg\" alt=\"\" width=\"120\" height=\"120\" \/>Farfan Sedano FJ, Oyag\u00fcez I, Apeztegu\u00eda Fern\u00e1ndez C, Casado MA<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<div class=\"col80p\">\n<h6 style=\"text-align: justify;\">Costes por recidiva evitada de natalizumab y fingolimod en el tratamiento de pacientes con esclerosis m\u00faltiple<\/h6>\n<h6><strong>57 Congreso de la Sociedad Espa\u00f1ola de Farmacia Hospitalaria (SEFH). Bilbao, Espa\u00f1a. 2-5 oct 2012<\/strong><\/h6>\n<\/div>\n<div id=\"archivoPublicacion\"><a href=\"https:\/\/porib.com\/wp-content\/uploads\/2021\/09\/100.pdf\" target=\"_blank\" rel=\"noopener\">POSTER<\/a><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Farfan Sedano FJ, Oyag\u00fcez I, Apeztegu\u00eda Fern\u00e1ndez C, Casado MA &nbsp; &nbsp; Costes por recidiva evitada de natalizumab y fingolimod en el tratamiento de pacientes con esclerosis m\u00faltiple 57 Congreso de la Sociedad Espa\u00f1ola de Farmacia Hospitalaria (SEFH). Bilbao, Espa\u00f1a. 2-5 oct 2012 POSTER<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"quote","meta":{"footnotes":""},"categories":[116,927,230],"tags":[],"class_list":["post-14397","post","type-post","status-publish","format-quote","hentry","category-ace-acu-tipo-de-proyecto","category-neurologia","category-sociedad-espanola-de-farmacia-hospitalaria","post_format-post-format-quote"],"translation":{"provider":"WPGlobus","version":"2.10.3","language":"en","enabled_languages":["es","en"],"languages":{"es":{"title":true,"content":true,"excerpt":false},"en":{"title":false,"content":false,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/14397"}],"collection":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/comments?post=14397"}],"version-history":[{"count":1,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/14397\/revisions"}],"predecessor-version":[{"id":14399,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/14397\/revisions\/14399"}],"wp:attachment":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/media?parent=14397"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/categories?post=14397"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/tags?post=14397"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}